N Sneige

Summary

Affiliation: The University of Texas
Country: USA

Publications

  1. ncbi High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer
    Henry M Kuerer
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 9:601-5. 2003
  2. ncbi Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome
    Nour Sneige
    Department of Pathology, Cytopathology Section, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Cytopathol 120:238-44. 2012
  3. ncbi Immunohistochemical characterization of subtypes of male breast carcinoma
    Yimin Ge
    Department of Pathology, The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX 77030, USA
    Breast Cancer Res 11:R28. 2009
  4. ncbi Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer
    Nour Sneige
    Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 19:622-9. 2006
  5. ncbi Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases
    Nour Sneige
    Division of Pathology and Laboratory Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 15:1044-50. 2002
  6. ncbi Low-grade (fibromatosis-like) spindle cell carcinoma of the breast
    N Sneige
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Am J Surg Pathol 25:1009-16. 2001
  7. ncbi Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
    G N Hortobagyi
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    J Natl Cancer Inst 92:225-33. 2000
  8. ncbi Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment
    C Xiao
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Oncol 22:1547-53. 2011
  9. ncbi Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma
    M P Hoang
    Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Oncol 19:865-71. 2001
  10. ncbi Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility
    G Landon
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 125:683-6. 2012

Collaborators

Detail Information

Publications81

  1. ncbi High and differential expression of HER-2/neu extracellular domain in bilateral ductal fluids from women with unilateral invasive breast cancer
    Henry M Kuerer
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 9:601-5. 2003
    ..Breast ductal fluid can be obtained from women by simple nipple aspiration and may be useful for analyzing the microenvironment of the breast...
  2. ncbi Peritoneal washing cytologic analysis of ovarian serous tumors of low malignant potential to detect peritoneal implants and predict clinical outcome
    Nour Sneige
    Department of Pathology, Cytopathology Section, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Cytopathol 120:238-44. 2012
    ..To the best of the authors' knowledge, the ability of peritoneal washing (PW) cytology to detect the presence and type of peritoneal implants has not been adequately investigated, and its prognostic significance is unknown...
  3. ncbi Immunohistochemical characterization of subtypes of male breast carcinoma
    Yimin Ge
    Department of Pathology, The Methodist Hospital, Weill Medical College of Cornell University, Houston, TX 77030, USA
    Breast Cancer Res 11:R28. 2009
    ....
  4. ncbi Correlation of cytologic findings and chromosomal instability detected by fluorescence in situ hybridization in breast fine-needle aspiration specimens from women at high risk for breast cancer
    Nour Sneige
    Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 19:622-9. 2006
    ..Studies evaluating the association between specific patterns of chromosomal polysomy and progression to malignancy may be warranted...
  5. ncbi Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases
    Nour Sneige
    Division of Pathology and Laboratory Medicine, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Mod Pathol 15:1044-50. 2002
    ..Long-term follow-up studies are needed to further define the natural history of PL/DLCIS and its optimal management...
  6. ncbi Low-grade (fibromatosis-like) spindle cell carcinoma of the breast
    N Sneige
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Am J Surg Pathol 25:1009-16. 2001
    ..Because FLSpCCs may be underdiagnosed as benign, the use of immunohistochemical studies, especially for cytokeratins and SMA, is essential in the evaluation of any spindle cell proliferations of the breast...
  7. ncbi Randomized trial of high-dose chemotherapy and blood cell autografts for high-risk primary breast carcinoma
    G N Hortobagyi
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    J Natl Cancer Inst 92:225-33. 2000
    ..We conducted a prospective randomized trial to compare standard-dose chemotherapy with the same therapy followed by high-dose chemotherapy. PATIENTS and..
  8. ncbi Stability of HER2-positive status in breast carcinoma: a comparison between primary and paired metastatic tumors with regard to the possible impact of intervening trastuzumab treatment
    C Xiao
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Ann Oncol 22:1547-53. 2011
    ....
  9. ncbi Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma
    M P Hoang
    Department of Pathology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA
    Int J Oncol 19:865-71. 2001
    ....
  10. ncbi Peritoneal washing cytology in patients with BRCA1 or BRCA2 mutations undergoing risk-reducing salpingo-oophorectomies: a 10-year experience and reappraisal of its clinical utility
    G Landon
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Gynecol Oncol 125:683-6. 2012
    ....
  11. ncbi Fine-needle aspiration cytology of recurrent and metastatic mixed mesodermal tumors
    W A Mourad
    University of Texas M D Anderson Cancer Center, Houston
    Diagn Cytopathol 11:328-32. 1994
    ..These findings confirm that the epithelial component is responsible for the malignant behaviour of MMMTs, and suggest that these lesions may need to be classified as sarcomatoid carcinomas rather than true carcinosarcomas...
  12. ncbi Expression of growth factor and chemokine receptors: new insights in the biology of inflammatory breast cancer
    N Cabioglu
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77230, USA
    Ann Oncol 18:1021-9. 2007
    ..Expression of CXCR4 and CCR7 along with the biomarkers HER2-neu and epidermal growth factor receptor (EGFR) was investigated in inflammatory breast cancer (IBC) to evaluate their prognostic implications...
  13. ncbi Age as a predictor of outcome for women with DCIS treated with breast-conserving surgery and radiation: The University of Texas M. D. Anderson Cancer Center experience
    Anuja Jhingran
    Division of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 54:804-9. 2002
    ..To analyze the long-term outcome of breast conservation therapy in patients with ductal carcinoma in situ (DCIS) in a single institution and to analyze the prognostic importance, if any, of young patient age...
  14. ncbi Cationic liposome-mediated E1A gene transfer to human breast and ovarian cancer cells and its biologic effects: a phase I clinical trial
    G N Hortobagyi
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 19:3422-33. 2001
    ....
  15. ncbi Changing trends in breast fine-needle aspiration: results of the Papanicolaou Society of Cytopathology Survey
    S O Tabbara
    Department of Pathology, The George Washington University Medical Center, Washington, DC 20037, USA
    Diagn Cytopathol 22:126-30. 2000
    ..The issue of specimen adequacy, however, remains controversial, with some laboratories utilizing quantitative criteria, while the majority do not. Diagn. Cytopathol. 2000;22:126-130...
  16. ncbi A single-gene biomarker identifies breast cancers associated with immature cell type and short duration of prior breastfeeding
    W F Symmans
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, 77030, USA
    Endocr Relat Cancer 12:1059-69. 2005
    ..036). GABApi gene expression is increased in breast cancers of immature (undifferentiated) cell type and is significantly associated with shorter lifetime history of breastfeeding and with high-grade breast cancer in Hispanic women...
  17. ncbi Neovascularization in mucinous ductal carcinoma in situ suggests an alternative pathway for invasion
    S A Gadre
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Histopathology 53:545-53. 2008
    ..The aim was to characterize mucinous DCIS (mDCIS) of the breast and to describe, to our knowledge for the first time, neovascularization in mucin...
  18. ncbi Fine-needle aspiration cytology of a case of oncocytic adrenocortical carcinoma
    S Krishnamurthy
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Diagn Cytopathol 22:299-303. 2000
    ..The patient underwent left radical nephrectomy as well as a combined cardiopulmonary bypass, with atriotomy and resection of the tumor from the right atrium and inferior vena cava. Three months of postoperative follow-up were uneventful...
  19. ncbi Paclitaxel in the multimodality treatment for inflammatory breast carcinoma
    M Cristofanilli
    Department of Breast Medical Oncology, University of Texas, M D Anderson Cancer Center, Houston, TX 77030, USA
    Cancer 92:1775-82. 2001
    ..Reports of significant clinical activity of paclitaxel in metastatic breast carcinoma led the authors to investigate the role of this drug in the management of IBC...
  20. ncbi Accuracy of cytologic diagnoses made from touch imprints of image-guided needle biopsy specimens of nonpalpable breast abnormalities
    N Sneige
    Department of Anatomic Pathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Diagn Cytopathol 23:29-34. 2000
    ..Increased experience with cytologic analysis of TIs improves the accuracy of cytologic diagnoses...
  21. ncbi Computerized image analysis of Ki-67 in ductal breast carcinoma in situ
    D G Menter
    Departments of Clinical Cancer Prevention and Pathology, University of Texas M. D. Anderson Cancer Center, Houston, Texas, USA
    Anal Quant Cytol Histol 23:218-28. 2001
    ..As such, this method can offer (1) less intraobserver and interobserver variability, (2) a digital archival record, and (3) a baseline for digital exchange of information between studies...
  22. ncbi Characterization of foam cells in nipple aspirate fluid
    S Krishnamurthy
    Department of Pathology, The University of Texas, MD Anderson Cancer Center, Houston, Texas 77030, USA
    Diagn Cytopathol 27:261-4; discussion 265. 2002
    ..There was no evidence, however, of cell junctions or tonofilaments. The immunocytochemical and electron microscopic findings of our study together clearly support a macrophage derivation for foam cells in nipple aspirate fluid...
  23. ncbi Downregulation of the cyclin-dependent kinase inhibitor p27kip1 might correlate with poor disease-free and overall survival in inflammatory breast cancer
    Ana Maria Gonzalez-Angulo
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77230 1439, USA
    Clin Breast Cancer 7:326-30. 2006
    ..The objective of this study was to evaluate whether p27kip1 downregulation is a prognostic factor in patients with inflammatory breast carcinoma (IBC)...
  24. ncbi Pharmacogenomic predictor of sensitivity to preoperative chemotherapy with paclitaxel and fluorouracil, doxorubicin, and cyclophosphamide in breast cancer
    Kenneth R Hess
    Department of Biostatistics and Applied Mathematics, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77230-1439, USA
    J Clin Oncol 24:4236-44. 2006
    ..This test correctly identified all but one of the patients who achieved pCR (12 of 13 patients) and all but one of those who were predicted to have residual disease had residual cancer (27 of 28 patients)...
  25. ncbi Sonographic and mammographic appearances of granular cell tumors of the breast with pathological correlation
    Wei Tse Yang
    Department of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Ultrasound 34:153-60. 2006
    ..CONCLUSIONS: Breast imagers should be aware that GCT of the breast is an uncommon differential in a minority of neoplasms that can be mistaken for breast cancer...
  26. ncbi Outcome after pathologic complete eradication of cytologically proven breast cancer axillary node metastases following primary chemotherapy
    Bryan T Hennessy
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Clin Oncol 23:9304-11. 2005
    ..The purpose of this study was to determine long-term outcome in patients achieving pCR of cytologically proven axillary lymph node (ALN) metastases...
  27. ncbi Fine needle aspiration cytology of well-differentiated papillary mesothelioma: a case report
    Yun Gong
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
    Acta Cytol 49:537-42. 2005
    ..Fine needle aspiration (FNA) of this type of tumor has rarely been reported...
  28. ncbi Impact of concurrent proliferative high-risk lesions on the risk of ipsilateral breast carcinoma recurrence and contralateral breast carcinoma development in patients with ductal carcinoma in situ treated with breast-conserving therapy
    Linda J Adepoju
    Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 106:42-50. 2006
    ..Concurrent ADH, ALH, or LCIS with DCIS is not a contraindication to BCT...
  29. ncbi Collagenous spherulosis of breast: morphologic study of 59 cases and review of the literature
    Erika Resetkova
    Department of Pathology, University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 30:20-7. 2006
    ..Caution is needed not to overinterpret collagenous spherulosis as atypical or ductal carcinoma in situ, especially on core needle biopsy specimens...
  30. ncbi The feasibility of gene expression profiling generated in fine-needle aspiration specimens from patients with follicular lymphoma and diffuse large B-cell lymphoma
    Andre Goy
    Department of Lymphoma and Myeloma, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 108:10-20. 2006
    ..The results support the feasibility of FNA-based transcription profiles in patients with FL or LBCL, which, in combination with morphology and immunophenotyping, can help in the subtyping of these entities...
  31. ncbi Locoregional recurrence after doxorubicin-based chemotherapy and postmastectomy: Implications for breast cancer patients with early-stage disease and predictors for recurrence after postmastectomy radiation
    Wendy A Woodward
    Department of Radiation Oncology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Int J Radiat Oncol Biol Phys 57:336-44. 2003
    ..CONCLUSIONS: Postmastectomy radiation decreases LRR for patients with breast cancer, including those with Stage II breast cancer and one to three positive lymph nodes...
  32. ncbi Beta4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer
    Leslie K Diaz
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 18:1165-75. 2005
    ....
  33. ncbi CD44 expression is associated with increased survival in node-negative invasive breast carcinoma
    Leslie K Diaz
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 11:3309-14. 2005
    ..The purpose of this study was to evaluate the prognostic significance of CD44 isoforms in early-stage, lymph node-negative invasive breast carcinoma...
  34. ncbi Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications
    Jason W Nash
    Departments of Pathology and Dermatology, University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    J Cutan Pathol 34:49-54. 2007
    ..In analogy to breast carcinoma, these findings suggest the applicability of trastuzumab for patients with metastatic adnexal carcinomas demonstrating Her-2/neu amplification...
  35. ncbi Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy
    Hiroaki Itamochi
    Department of Stem Cell Transplantation and Cellular Therapy, Unit 448, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Mol Cancer Ther 6:227-35. 2007
    ..001). E1A gene therapy, because of its ability to stabilize wild-type p53, is worth exploring as a treatment modality for women with ovarian CCC, which typically expresses wild-type p53...
  36. ncbi Human papillomavirus genotyping for the eight oncogenic types can improve specificity of HPV testing in women with mildly abnormal Pap results
    Ming Guo
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Mod Pathol 21:1037-43. 2008
    ....
  37. ncbi Metastases to intramammary lymph nodes in patients with breast cancer: sonographic findings
    Beth S Edeiken-Monroe
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    J Clin Ultrasound 36:279-85. 2008
    ....
  38. ncbi Clinical, histopathologic, and immunohistochemical features of microglandular adenosis and transition into in situ and invasive carcinoma
    Ibrahim M Khalifeh
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Am J Surg Pathol 32:544-52. 2008
    ....
  39. ncbi Assessment of two automated imaging systems in evaluating estrogen receptor status in breast carcinoma
    Sumita Gokhale
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Appl Immunohistochem Mol Morphol 15:451-5. 2007
    ..In 4 of these, the percentage of cells staining for ER was low (0% to 20%). Overall, the 2 systems were comparable, and discrepant results were most frequently seen when analyzing tumors with low levels of ER positive cells...
  40. ncbi Thyroid transcription factor-1 expression in endometrial and endocervical adenocarcinomas
    Koushan Siami
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030 4009, USA
    Am J Surg Pathol 31:1759-63. 2007
    ..It should also be taken into consideration in the evaluation of adenocarcinomas involving the lung in patients with a history of a gynecologic malignancy...
  41. ncbi Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice
    Leslie K Diaz
    Piper Breast Center, Virginia Piper Cancer Institute, Abbott Northwestern Hospital, Minneapolis, MN 55407, USA
    Adv Anat Pathol 14:419-30. 2007
    ....
  42. ncbi Evaluation of a commercialized in situ hybridization assay for detecting human papillomavirus DNA in tissue specimens from patients with cervical intraepithelial neoplasia and cervical carcinoma
    Ming Guo
    Department of Pathology, Unit 58, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 4009, USA
    J Clin Microbiol 46:274-80. 2008
    ..In addition, signal patterns, especially a mixed punctate and diffuse pattern of HPV, cannot be reliably used to predict viral integration status...
  43. ncbi A human papillomavirus testing system in women with abnormal Pap results: a comparison study with follow-up biopsies
    Ming Guo
    Departments of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 4009, USA
    Acta Cytol 51:749-54. 2007
    ..To evaluate the efficacy of INFORM HPV using the SurePath collection method in women whose Pap tests indicated abnormal results...
  44. ncbi Breast carcinoma arising in microglandular adenosis: a review of the literature
    Afshin Salarieh
    Division of Pathology and Laboratory Medicine, The University of Texas M D Anderson Cancer Center, Houston, USA
    Arch Pathol Lab Med 131:1397-9. 2007
    ....
  45. ncbi Comparison of ductal lavage and random periareolar fine needle aspiration as tissue acquisition methods in early breast cancer prevention trials
    Banu Arun
    Breast Medical Oncology, The University of Texas, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 13:4943-8. 2007
    ..The optimum method to retrieve adequate samples and the most accepted method by study participants is not known...
  46. ncbi Inflammatory breast cancer (IBC) and patterns of recurrence: understanding the biology of a unique disease
    Massimo Cristofanilli
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 110:1436-44. 2007
    ..The authors compared the prognostic features of IBC and non-IBC locally advanced breast cancer (LABC) to gain insight into the biology of this disease entity...
  47. ncbi Determination of oestrogen-receptor status and ERBB2 status of breast carcinoma: a gene-expression profiling study
    Yun Gong
    Department of Pathology, University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Lancet Oncol 8:203-11. 2007
    ..Our goal was to establish a new method to assign oestrogen receptor and ERBB2-receptor status to breast carcinoma based on mRNA expression measured using Affymetrix U133A gene-expression profiling...
  48. ncbi Distribution and viral load of eight oncogenic types of human papillomavirus (HPV) and HPV 16 integration status in cervical intraepithelial neoplasia and carcinoma
    Ming Guo
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030 4009, USA
    Mod Pathol 20:256-66. 2007
    ..We also conclude that the HPV 16 integration status has potential to be a marker for risk assessment of CIN progression...
  49. ncbi Reliability of chromogenic in situ hybridization for detecting HER-2 gene status in breast cancer: comparison with fluorescence in situ hybridization and assessment of interobserver reproducibility
    Yun Gong
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA
    Mod Pathol 18:1015-21. 2005
    ..We conclude that, in general, HER-2 status can be reliably assessed by CISH. Confirmatory FISH is recommended in cases with equivocal or borderline CISH copy numbers...
  50. ncbi Validation of commonly used immunostains on cell-transferred cytologic specimens
    Yun Gong
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 105:158-64. 2005
    ..However the reliability of the staining results has not been systematically evaluated...
  51. ncbi Total RNA yield and microarray gene expression profiles from fine-needle aspiration biopsy and core-needle biopsy samples of breast carcinoma
    W Fraser Symmans
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 97:2960-71. 2003
    ..This study compared gene expression profiles derived from fine-needle aspiration biopsy (FNAB) and from core needle biopsy (CBX)...
  52. ncbi Nipple aspirate fluid cytology in breast carcinoma
    Savitri Krishnamurthy
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 99:97-104. 2003
    ..Cytologic-histologic correlations of NAF were performed in only a few studies...
  53. ncbi Histologic localization of sentinel lymph node metastases in breast cancer
    Leslie K Diaz
    Department of Pathology, M.D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Am J Surg Pathol 27:385-9. 2003
    ..This information may be useful in determining the optimal method for evaluating axillary sentinel lymph node specimens from breast cancer patients...
  54. ncbi Lobular carcinoma in situ diagnosed by core needle biopsy: when should it be excised?
    Lavinia P Middleton
    Department of Pathology, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Mod Pathol 16:120-9. 2003
    ..Based on these findings, we recommend excisional biopsy of lobular carcinoma in situ, atypical lobular hyperplasia or lobular neoplasia only when it is associated with a synchronous mass lesion...
  55. ncbi Mammographic-pathologic correlation of apocrine metaplasia diagnosed using vacuum-assisted stereotactic core-needle biopsy: our 4-year experience
    Anne C Kushwaha
    Division of Diagnostic Radiology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Box 57, Houston, TX 77030, USA
    AJR Am J Roentgenol 180:795-8. 2003
    ..Because no distinguishing mammographic features are present to require follow-up by imaging, needle biopsy is required for definitive diagnosis...
  56. ncbi Atypical ductal hyperplasia diagnosis by directional vacuum-assisted stereotactic biopsy of breast microcalcifications. Considerations for surgical excision
    Nour Sneige
    Department of Pathology, University of Texas M.D. Anderson Cancer Center, Unit 53, 1515 Holcombe Blvd, Houston, TX 77030, USA
    Am J Clin Pathol 119:248-53. 2003
    ..When assessing microcalcifications with ADH, clinicians should consider the percentage of microcalcifications removed by DVAB and the extent of lobular involvement to better assess the need for excision...
  57. ncbi Phase II study of weekly docetaxel and trastuzumab for patients with HER-2-overexpressing metastatic breast cancer
    Francisco J Esteva
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA
    J Clin Oncol 20:1800-8. 2002
    ..To evaluate the safety and efficacy of weekly docetaxel plus trastuzumab in women with HER-2-overexpressing metastatic breast cancer. Efficacy was correlated with serum HER-2 extracellular domain (ECD) levels...
  58. ncbi Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia
    S Eva Singletary
    Department of Surgical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 8:2835-42. 2002
    ..Surrogate end point biomarkers (SEBs) that can be measured in ductal carcinoma in situ or early-stage invasive cancer are needed to improve the efficiency and reduce the cost of chemoprevention trials...
  59. ncbi Role of ultrasound-guided fine-needle aspiration of indeterminate and suspicious axillary lymph nodes in the initial staging of breast carcinoma
    Savitri Krishnamurthy
    Department of Pathology, M D Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 95:982-8. 2002
    ..This study was undertaken to determine the diagnostic accuracy of US-guided FNA of indeterminate/suspicious/metastatic-appearing axillary lymph nodes during the initial staging of breast carcinoma...
  60. ncbi Intraoperative touch imprint of sentinel lymph nodes in breast carcinoma patients
    Andrea Lee
    Department of Pathology, University of Texas M.D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 96:225-31. 2002
    ..The difficulty of identifying micrometastases appeared to be the major source of false negative events, a problem that is not unique to TI cytology...
  61. ncbi Pathologic tumor size and lymph node status predict for different rates of locoregional recurrence after mastectomy for breast cancer patients treated with neoadjuvant versus adjuvant chemotherapy
    Thomas A Buchholz
    Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX 77030, USA
    Int J Radiat Oncol Biol Phys 53:880-8. 2002
    ..To compare the pathologic factors associated with postmastectomy locoregional recurrence (LRR) in breast cancer patients not receiving radiation who were treated with neoadjuvant chemotherapy (NEO) vs. adjuvant chemotherapy (ADJ)...
  62. ncbi Her-2/neu gene amplification in ductal carcinoma in situ of the breast
    Ashraful Hoque
    Departments of Clinical Cancer Prevention, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer Epidemiol Biomarkers Prev 11:587-90. 2002
    ..g., p21 and Rb) as markers of the risk of DCIS patients for invasive breast cancer and as molecular targets of chemoprevention in breast intraepithelial neoplasia...
  63. ncbi Interventional breast sonography
    Bruno D Fornage
    Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, Box 57, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Eur J Radiol 42:17-31. 2002
    ..However, on occasion, clusters of microcalcifications without a mass can be visualized on sonograms with sufficient clarity to undertake a US-guided core biopsy if stereotactically guided biopsy cannot be performed for technical reasons...
  64. ncbi Gene expression profiles obtained from fine-needle aspirations of breast cancer reliably identify routine prognostic markers and reveal large-scale molecular differences between estrogen-negative and estrogen-positive tumors
    Lajos Pusztai
    Departments of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030 009, USA
    Clin Cancer Res 9:2406-15. 2003
    ..33)P]dCTP-labeled cDNA probes were generated and hybridized to cDNA membrane microarrays that contained 30,000 human sequence clones, including 10,890 expressed sequence tags...
  65. ncbi Detection of numerical aberrations of chromosomes 7 and 9 in cytologic specimens of pleural malignant mesothelioma
    Hyung Ju C Shin
    Department of Pathology, The University of Texas M D Anderson Cancer Center, Houston, Texas, USA
    Cancer 99:233-9. 2003
    ..The authors attempted to determine whether the detection of numerical chromosomal aberrations in the effusion fluid specimens could be a useful diagnostic adjunct in morphologically inconclusive cases for MM...
  66. ncbi Accuracy of core needle biopsy diagnosis in assessing papillary breast lesions: histologic predictors of malignancy
    Doina Ivan
    Department of Pathology, The University of Texas-Houston, Houston, TX, USA
    Mod Pathol 17:165-71. 2004
    ..0001) than is the presence of mitoses (P<0.053). A diagnosis of carcinoma or atypical papilloma by CNB should warrant an EB, whereas benign papillomas may be followed if imaging findings are concordant...
  67. ncbi Comparison of HER-2 status determined by fluorescence in situ hybridization in primary and metastatic breast carcinoma
    Yun Gong
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 103:1763-9. 2005
    ..Therefore, HER-2 amplification can be evaluated reliably in material from either primary or metastatic tumors in most patients. Further study with larger series is warranted to elucidate the significance of discordant results...
  68. ncbi Pathologic quiz case: a large, ill-defined cystic breast mass. Invasive cystic hypersecretory duct carcinoma
    Erika Resetkova
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston 77030, USA
    Arch Pathol Lab Med 129:e79-80. 2005
  69. ncbi Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes
    Massimo Cristofanilli
    Department of Breast Medical Oncology, Unit 424, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030 4009, USA
    J Clin Oncol 23:41-8. 2005
    ..To investigate the impact of histologic type invasive lobular carcinoma (ILC) versus invasive ductal carcinoma (IDC) on response to primary chemotherapy (PC) and long-term outcome...
  70. ncbi Estrogen receptor analysis for breast cancer: current issues and keys to increasing testing accuracy
    Leslie K Diaz
    Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA
    Adv Anat Pathol 12:10-9. 2005
    ..We additionally highlight recent biologic, molecular, and gene expression profiling data related to ER in breast cancer...
  71. ncbi Fine-needle aspiration cytology of a liver metastasis of follicular dendritic cell sarcoma
    Rulong Ren
    Department of Pathology, Ball Memorial Hospital, Muncie, Indiana, USA
    Diagn Cytopathol 32:38-43. 2005
    ..We review the literature on this entity with emphasis on FNA cytomorphology, differential diagnosis, and immunohistochemical findings...
  72. ncbi p53 expression as a prognostic marker in inflammatory breast cancer
    Ana M Gonzalez-Angulo
    Department of Breast Medical Oncology, The University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Clin Cancer Res 10:6215-21. 2004
    ..We retrospectively analyze the expression of p53 as a prognostic marker to predict pathological complete response and survival in patients with IBC...
  73. ncbi Feasibility and utility of using chromosomal aneusomy to further define the cytologic categories in nipple aspirate fluid specimens: a preliminary study
    Savitri Krishnamurthy
    Department of Cytopathology, Unit 53, The University of Texas M D Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX 77030, USA
    Cancer 102:322-7. 2004
    ....
  74. ncbi Prognostic value of P53, MDM-2, and MUC-1 for patients with inflammatory breast carcinoma
    Erika Resetkova
    Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston 77030, USA
    Cancer 101:913-7. 2004
    ..CONCLUSIONS: Expression of P53 and MUC-1 may be predictive of treatment efficacy and outcome for patients with IBC. Furthermore, these two markers may represent novel therapeutic targets in such patients...
  75. ncbi Expression of BAG-1 and BcL-2 proteins before and after neoadjuvant chemotherapy of locally advanced breast cancer
    Lajos Pusztai
    Department of Breast Medical Oncology, University of Texas M D Anderson Cancer Center, Box 424, 1515 Holcombe Blvd, Houston, TX 77030 4009, USA
    Cancer Invest 22:248-56. 2004
    ..However, it does not appear to determine response to doxorubicin-based chemotherapy. In contrast, lack of Bcl-2 expression was associated with a higher probability of complete pathological response to doxorubicin-based chemotherapy...
  76. ncbi Interobserver agreement of a probabilistic approach to reporting breast fine-needle aspirations on ThinPrep
    Bradley Gornstein
    Department of Pathology, Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA
    Diagn Cytopathol 30:389-95. 2004
    ..The specific level of experience interpreting breast FNA or using ThinPrep among experienced pathologists did not seem to influence their accuracy in reporting the cases in our study...
  77. ncbi The use of TMA for interlaboratory validation of FISH testing for detection of HER2 gene amplification in breast cancer
    Leslie K Diaz
    Department of Pathology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    J Histochem Cytochem 52:501-7. 2004
    ..Good concordance was observed between HER2 IHC and in situ hybridization testing. TMA is a robust and effective method for the technical validation of HER2 FISH testing and should be considered for use by quality assessment programs...
  78. ncbi Utility of cytologic specimens in the evaluation of prognostic and predictive factors of breast cancer: current issues and future directions
    Nour Sneige
    Department of Pathology, University of Texas M D Anderson Cancer Center, Houston, Texas 77030, USA
    Diagn Cytopathol 30:158-65. 2004
    ..Such investigational studies are under way and offer great potential for revolutionizing the prediction of patient outcomes and disease response to therapy, as well as assessment of risk of developing breast cancer...
  79. ncbi Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma
    Yun Gong
    Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA
    Cancer 102:34-40. 2004
    ..Air-drying, destaining Pap smear, and fixation in formalin or Carnoy's-Pap without antigen retrieval are not recommended...
  80. ncbi Immunocytochemical evaluation of estrogen receptor on archival Papanicolaou-stained fine-needle aspirate smears
    Savitri Krishnamurthy
    Department of Pathology, MD Anderson Cancer Center, The University of Texas, Houston, Texas 77030, USA
    Diagn Cytopathol 29:309-14. 2003
    ..Because significant differences in ER-IC staining can occur with any of the immunocytochemical methods, a negative result is less reliable as an indicator of true ER status than a positive result...
  81. ncbi Molecular and biologic markers of premalignant lesions of human breast
    Savitri Krishnamurthy
    Department of Pathology, The University of Texas, M.D. Anderson Cancer Center, Houston, USA
    Adv Anat Pathol 9:185-97. 2002
    ....